CAM
ROIV icon

Costello Asset Management’s Roivant Sciences ROIV Stock Holding History

Costello Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$4.54K – 721
2025
Q3 		$4.54K Sell
300
-500
-63% -$6.19K ﹤0.01% 551
2025
Q2 		$9.02K Hold
800
– – ﹤0.01% 487
2025
Q1 		$8.07K Buy
+800
New +$8.65K ﹤0.01% 475

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Costello Asset Management's ROIV Position: Q4 2025 in Review

Costello Asset Management sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 300 shares — an estimated $4.54K sold.

Costello Asset Management first reported a position in ROIV in Q1 2025 and held it in 3 quarters. The position peaked at $9.02K in Q2 2025. 398 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Costello Asset Management reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Costello Asset Management sold 300 Roivant Sciences shares in Q4 2025, an estimated $4.54K.
  • Costello Asset Management first reported a position in Roivant Sciences in Q1 2025 and held it in 3 quarters.
  • Costello Asset Management's Roivant Sciences position peaked at $9.02K in Q2 2025.
  • 398 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Costello Asset Management's 13F filing for Q4 2025, filed 3 Feb 2026.